Imaging features of primary and secondary malignant tumours of the sacrum

British Journal of Radiology

Volumn 85, Issue 1011, 2012, Pages 279-286

  Thornton, Eavan ^a   Krajewski, K M ^a   O'Regan, K N ^a   Giardino, A A ^a   Jagannathan, J P ^a   Ramaiya, N ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BONE CANCER; BONE RESECTION; CANCER CHEMOTHERAPY; CHONDROSARCOMA; CHORDOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; EWING SARCOMA; HUMAN; LYMPHOMA; MULTIPLE MYELOMA; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PLASMACYTOMA; REVIEW; SACRUM; SACRUM CANCER;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHORDOMA; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC NEOPLASMS; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; OSTEOSARCOMA; POSITRON-EMISSION TOMOGRAPHY; SACRUM; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84857932332     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/25247602     Document Type: Review

References (25)

1. Diel J, Ortiz O, Losada RA, Price DB, Hayt MW, Katz DS. The sacrum: pathologic spectrum, multimodality imaging, and subspecialty approach. Radiographics 2001;21:83-104. (Pubitemid 33707411)
2. Ha S. Imaging of sacral masses: self-assessment module. AJR Am J Roentgenol 2010;195:S32-6.
3. Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am 2005;87:2211-16. (Pubitemid 41407545)
4. Gerber S, Ollivier L, Leclere J, Vanel D, Missenard G, Brisse H, et al. Imaging of sacral tumours. Skeletal Radiol 2008;37:277-89.
5. Murphey MD, Andrews CL, Flemming DJ, Temple HT, Smith WS, Smirniotopoulos JG. From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation. Radiographics 1996;16:1131-58. (Pubitemid 126448475)
6. Sung MS, Lee GK, Kang HS, Kwon ST, Park JG, Suh JS, et al. Sacrococcygeal chordoma: MR imaging in 30 patients. Skeletal Radiol 2005;34:87-94. (Pubitemid 40174013)
7. Miyazawa N, Ishigame K, Kato S, Satoh Y, Shinohara T. Thoracic chordoma: reviewand role of FDG-PET. J Neurosurg Sci 2008;52:117-21; discussion 121-2.
8. Park SA, Kim HS. F-18 FDG PET/CT evaluation of sacrococcygeal chordoma. Clin Nucl Med 2008;33:906-8.
9. Rodallec MH, Feydy A, Larousserie F, Anract P, Campagna R, Babinet A, et al. Diagnostic imaging of solitary tumors of the spine: what to do and say. Radiographics 2008; 28:1019-41.
10. Murphey MD, Walker EA, Wilson AJ, Kransdorf MJ, Temple HT, Gannon FH. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics 2003;23:1245-78. (Pubitemid 37414739)
11. Gelderblom H, Hogendoorn PC, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AH, et al. The clinical approach towards chondrosarcoma. Oncologist 2008;13:320-9. (Pubitemid 351679908)
12. Manaster BJ, Graham T. Imaging of sacral tumors. Neurosurg Focus 2003;15:E2.
13. Llauger J, Palmer J, Amores S, Bague S, Camins A. Primary tumors of the sacrum: diagnostic imaging. AJR Am J Roentgenol 2000;174:417-24. (Pubitemid 30067150)
14. Schulte M, Brecht-Krauss D, Werner M, Hartwig E, Sarkar MR, Keppler P, et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. J Nucl Med 1999;40:1637-43. (Pubitemid 29471153)
15. Hogendoorn PC, Athanasou N, Bielack S, De Alava E, Dei Tos AP, Ferrari S, et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl. 5):v204-13.
16. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet 2001;130:1-7. (Pubitemid 32982126)
17. Disler DG, Miklic D. Imaging findings in tumors of the sacrum. AJR Am J Roentgenol 1999;173:1699-706.
18. Becker S, Babisch J, Venbrocks R, Katenkamp D, Wurdinger S. Primary non-Hodgkin lymphoma of the spine. Arch Orthop Trauma Surg 1998;117:399-401. (Pubitemid 28365076)
19. Yamamoto Y, Taoka T, Nakamine H. Superior clinical impact of FDG-PET compared to MRI for the follow-up of a patient with sacral lymphoma. J Clin Exp Hematop 2009;49:109-15.
20. Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005;35:135-42. (Pubitemid 40568746)
21. Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 1996;199:751-6.
22. Kosaka N, Maeda M, Uematsu H, Matsumine A, Koshimoto Y, Itoh H. Solitary plasmacytoma of the sacrum. Radiologic findings of three cases. Clin Imaging 2005;29:426-9. (Pubitemid 41597081)
23. Puri A, Agarwal MG, Shah M, Srinivas CH, Shukla PJ, Shrikhande SV, et al. Decision making in primary sacral tumors. Spine J 2009;9:396-403.
24. Fourney DR, Rhines LD, Hentschel SJ, Skibber JM, Wolinsky JP, Weber KL, et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 2005;3:111-22.
25. Sciubba DM, Petteys RJ, Garces-Ambrossi GL, Noggle JC, McGirt MJ, Wolinsky JP, et al. Diagnosis and management of sacral tumors. J Neurosurg Spine 2009;10:244-56.